心脏介入术后对比剂肾病的临床分析

目的 通过对心脏介入术后对比剂肾病(contrast-induced nephropathy,CIN)的临床分析,提高相关专业医生对对比剂危害的认识.方法 对2010年6月至2011年3月行冠状动脉支架植入术治疗的178例患者术后回访3周,检测其术前、术后48 h、术后3周血清肌酐水平；对CIN的发生情况进行统计.结果 CIN患者11例,对比剂用量增加,明显提高了CIN发生率(P＜0.01).结论 术者应该严格控制对比剂用量,有效预防和控制CIN的发生.

Clinical analysis of contrast-induced nephropathy after cardiac intervention operation

Objective To improve the related professional physician′s awareness of the contrast harm by clinical analysis on contrast-induced nephropathy(CIN) after cardiac intervention operation.Methods From June 2010 to March 2011,178 cases of coronary stent implantation were followed up for postoperative 3 weeks and tested the serum creatinine levels before operation,at 48 h and 3 weeks after transplantation.The occurrence status of CIN was statistically analyzed.Results Increasing the dosage of contrast agent in 11 patients with CIN,incidence of CIN was improved significantly(P<0.01).Conclusion The operator should pay attention to control the contrast agent dosage,effectively prevent and control the occurrrence of CIN.